SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Assets | ₹1,155 Cr | ₹1,265 Cr | ₹667 Cr | ₹511 Cr | ₹423 Cr |
What is the latest Total Current Assets ratio of SUVEN PHARMACEUTICALS ?
Year | Total Current Assets |
---|---|
Mar2023 | ₹1,155 Cr |
Mar2022 | ₹1,265 Cr |
Mar2021 | ₹667 Cr |
Mar2020 | ₹511 Cr |
Mar2019 | ₹423 Cr |
How is Total Current Assets of SUVEN PHARMACEUTICALS Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹1,155 Cr | -8.68 | |
Mar2022 | ₹1,265 Cr | 89.81 | |
Mar2021 | ₹667 Cr | 30.41 | |
Mar2020 | ₹511 Cr | 20.89 | |
Mar2019 | ₹423 Cr | - |
Compare Total Current Assets of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹16,472.6 Cr | 2.8% | 0.4% | 35.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -1.1% | -2.9% | 55.1% | Stock Analytics | |
CIPLA | ₹120,556.0 Cr | 0.3% | 6.1% | 56.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹118,095.0 Cr | 8.2% | 11.5% | 27.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -3.7% | 8.5% | 107.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.8% | -4.7% | 32.3% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 2.8% |
0.4% |
35.6% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses